This invention describes a class of compounds able to activate the human SIRT1 enzyme and regulate many metabolic functions. This invention consists of compounds that can be employed in medical applications, specifically for the treatment or prevention of cardiometabolic diseases, such as diabetes, and of cardiovascular disorders, such as coronaropathy, heart failure and atherosclerosis.

New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies

CALDERONE Vincenzo;MINUTOLO Filippo;TUCCINARDI Tiziano;TESTAI Lara;GRANCHI Carlotta;MARTELLI Alma;CITI Valentina;
2019

Abstract

This invention describes a class of compounds able to activate the human SIRT1 enzyme and regulate many metabolic functions. This invention consists of compounds that can be employed in medical applications, specifically for the treatment or prevention of cardiometabolic diseases, such as diabetes, and of cardiovascular disorders, such as coronaropathy, heart failure and atherosclerosis.
File in questo prodotto:
File Dimensione Formato  
Patent_SIRT_WO2019162911A1_Original_document_20200116145118.pdf

accesso aperto

Descrizione: Domanda di brevetto internazionale completa
Tipologia: Versione finale editoriale
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 3.78 MB
Formato Adobe PDF
3.78 MB Adobe PDF Visualizza/Apri
21.U0053.12.WO.5@Pub_(WO2019-162911-A8)_risposta depositata.pdf

accesso aperto

Descrizione: errata corrige
Tipologia: Altro materiale allegato
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 89.71 kB
Formato Adobe PDF
89.71 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/1023080
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact